Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1634
https://www.valueinhealthjournal.com/article/S1098-3015(18)31940-5/fulltext
Title :
Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31940-5&doi=10.1016/j.jval.2018.04.1634
First page :
Section Title :
Open access? :
No
Section Order :
852